These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11642024)

  • 1. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
    Pham Dang C; Gouin F; Touchais S; Richard C; Potel G
    Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
    Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
    J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methicillin resistant staphylococci].
    Afanas'eva TI
    Antibiot Khimioter; 1998; 43(6):29-31. PubMed ID: 9644532
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
    Marshall C; Street A; Galbraith K
    J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Intraarticular Antibiotic Administration Effective in the Treatment of Methicillin-Resistant Staphylococcus aureus?
    Kuyucu E; Çabuk H; Güler Y; Çabuk F; Kiliç E; Bülbül M
    Acta Chir Orthop Traumatol Cech; 2019; 86(4):276-280. PubMed ID: 31524589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vancomycin and teicoplanin use as antibiotic prophylaxis in cardiac surgery: pharmacoeconomic study].
    Codina C; Miró JM; Tuset M; Claramonte J; Gomar C; Gotsens R; Gómez B; Suárez S; Abellana R; Ascaso C; Cartaña R; Rodríguez E; Asenjo M; Carné X; Trilla A; Marco F; Gómez J; Brunet M; Pomar JL; Gatell JM; Ribas J
    Med Clin (Barc); 2000; 114 Suppl 3():54-61. PubMed ID: 10994565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis].
    Jourdan C; Convert J; Peloux A; Boussaid O; Grando J; Tigaud S
    Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological considerations in the economic evaluation of glycopeptides].
    García-Quetglas E; Sádaba B; Honorato J
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():68-73. PubMed ID: 9441326
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are glycopeptides still appropriate and convenient for empiric use?
    Gonzalez-Ruiz A; Richardson J
    J Chemother; 2008 Oct; 20(5):531-41. PubMed ID: 19028614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis.
    Ramírez Hidalgo M; Jover-Sáenz A; García-González M; Barcenilla-Gaite F
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Feb; 36(2):142-143. PubMed ID: 28600171
    [No Abstract]   [Full Text] [Related]  

  • 19. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
    Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
    Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs associated with using vancomycin in methicillin-resistant Staphylococcus aureus infections: an economic model.
    Shah NP; Reddy P; Paladino JA; McKinnon PS; Klepser ME; Pashos CL
    Curr Med Res Opin; 2004 Jun; 20(6):779-90. PubMed ID: 15200734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.